Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)

NCT04400032 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT04400032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 1/2
Overall status
Completed
Start date
May 15, 2020
Completion date
April 22, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid19